Conning Inc’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-11,482
| Closed | -$1.14M | – | 518 |
|
|
2019
Q3 | $1.14M | Buy |
11,482
+20
| +0.2% | +$1.9K | 0.04% | 202 |
|
|
2019
Q2 | $1.06M | Sell |
11,462
-1,972
| -15% | -$187K | 0.04% | 213 |
|
|
2019
Q1 | $1.27M | Sell |
13,434
-340
| -2% | -$29.7K | 0.04% | 225 |
|
|
2018
Q4 | $883K | Sell |
13,774
-3,610
| -21% | -$266K | 0.03% | 243 |
|
|
2018
Q3 | $1.56M | Sell |
17,384
-1,950
| -10% | -$172K | 0.05% | 216 |
|
|
2018
Q2 | $1.54M | Sell |
19,334
-2,780
| -13% | -$231K | 0.05% | 228 |
|
|
2018
Q1 | $1.97M | Buy |
22,114
+1,790
| +9% | +$172K | 0.06% | 186 |
|
|
2017
Q4 | $2.12M | Sell |
20,324
-430
| -2% | -$48.5K | 0.07% | 178 |
|
|
2017
Q3 | $3.03M | Sell |
20,754
-90
| -0.4% | -$12.3K | 0.1% | 143 |
|
|
2017
Q2 | $2.71M | Sell |
20,844
-96
| -0.5% | -$11.8K | 0.1% | 149 |
|
|
2017
Q1 | $2.61M | Sell |
20,940
-1,535
| -7% | -$184K | 0.1% | 149 |
|
|
2016
Q4 | $2.6M | Buy |
22,475
+2,955
| +15% | +$329K | 0.1% | 148 |
|
|
2016
Q3 | $2.04M | Buy |
19,520
+60
| +0.3% | +$6.49K | 0.08% | 180 |
|
|
2016
Q2 | $1.92M | Buy |
19,460
+30
| +0.2% | +$3.1K | 0.08% | 189 |
|
|
2016
Q1 | $1.95M | Buy |
19,430
+320
| +2% | +$33K | 0.08% | 175 |
|
|
2015
Q4 | $2.29M | Sell |
19,110
-1,090
| -5% | -$126K | 0.1% | 161 |
|
|
2015
Q3 | $2.19M | Sell |
20,200
-2,110
| -9% | -$262K | 0.1% | 157 |
|
|
2015
Q2 | $2.58M | Sell |
22,310
-350
| -2% | -$40K | 0.11% | 150 |
|
|
2015
Q1 | $2.61M | Sell |
22,660
-1,390
| -6% | -$166K | 0.11% | 136 |
|
|
2014
Q4 | $2.69M | Sell |
24,050
-800
| -3% | -$84.4K | 0.13% | 124 |
|
|
2014
Q3 | $2.35M | Sell |
24,850
-1,310
| -5% | -$118K | 0.12% | 127 |
|
|
2014
Q2 | $2.25M | Sell |
26,160
-440
| -2% | -$33.5K | 0.12% | 133 |
|
|
2014
Q1 | $1.86M | Buy |
26,600
+1,060
| +4% | +$83.9K | 0.11% | 149 |
|
|
2013
Q4 | $2.16M | Sell |
25,540
-262
| -1% | -$20.7K | 0.13% | 120 |
|
|
2013
Q3 | $1.99M | Buy |
25,802
+5,022
| +24% | +$352K | 0.15% | 118 |
|
|
2013
Q2 | $1.22M | Buy |
+20,780
| New | +$1.25M | 0.1% | 156 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Conning Inc's CELG Position: Q4 2019 in Review
Conning Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,482 shares — an estimated $1.14M sold.
Conning Inc first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.03M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Conning Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Conning Inc sold 11,482 Celgene Corp shares in Q4 2019, an estimated $1.14M.
- Conning Inc first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Conning Inc's Celgene Corp position peaked at $3.03M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Conning Inc's 13F filing for Q4 2019, filed 29 Jan 2020.